Antibiotics Market Size Worth $59.6 Billion By 2025 | CAGR: 4.9% : AnalystView Market Insights

The global antibiotics market is expected to grow at growth rate of 4.9% to reach USD 59.6 billion by 2025.

Rising prevalence of infectious and chronic diseases drive the market growth to great extent. For example, according to the Epidemiology & Community Health Research, infectious diseases remain one of the most important causes of mortality and morbidity across the globe. This would, in turn, increase the demand for antibiotics, driving the market growth. In addition, rising approval of novel and effective antibiotics by government organizations drive the market growth. For example, in February 2015, AstraZeneca’s Ceftazidime-avibactam (Avycaz) was approved by the U.S. FDA for the treatment of complicated intra-abdominal (cIAI) infections. Similarly, in May 2014, the U.S. FDA approved Dalbavancin (Dalvance) for the treatment of acute bacterial skin and skin structure infections. All such factors, along with, rising geriatric population, advancement in technologies, and increasing demand for effective therapeutics are driving the industry demand. However, stringent regulatory policies, high research and development cost and growing concern over antibiotic overuse are likely to hamper the market growth over the future period.

Browse the full report content here:
http://www.analystviewmarketinsights.com/report-highlight-antibiotics-market/

Key Takeaways

- Of the different inhibitor types, cell wall synthesis segment accounted for the highest share of the total market. In 2017, the segment captured around 42% share and is projected to dominate the industry.
- RNA segment is projected to grow with the highest growth rate and is pegged to register a 6.2% CAGR in terms of value.
- Drug class is categorized into Cephalosporin, Fluoroquinolones, Macrolides, Carbapenems, Penicillin, Aminoglycosides, and other. Among which, cephalosporin is the highest revenue generating segment throughout the study period.
- Geographically, Asia Pacific region is accounted for the largest share. Whereas, regions such as North America and European countries are growing with the strong growth rate during the foreseeable future.
- Novartis AG, Johnson & Johnson, Pfizer, Inc., GlaxoSmithKline, Bayer AG, and AstraZeneca are profiled in detail with the attributes such as company overview, financial performance, and key developments.
- Strategic collaborations are one of the most important strategies adopted by key players to expand their presence. For instance, in November 2017, Melinta Therapeutics, Inc. privately held novel broad-spectrum antibiotics developer, acquired the Medicines Company. This acquisition has helped Melinta to expand its product portfolio by addition Medicines’ marketed products such as Orbactiv (oritavancin), Vabomere (vaborbactam/meropenem), and Minocin IV (minocycline).

KEY BENEFITS OF THE REPORT

In-depth analysis of the key market dynamics
Granular analysis of the current market scenario and expected factors to affect the market
Detailed analysis of the geographic region, regional and county wise analysis
Highlight on the strategies that are being adopted by the key players in this market to stay competitive
Extensive analysis of the key players dominating the market
The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation

MARKET, BY INHIBITOR TYPE

Protein Synthesis Inhibitors
Cell Wall Synthesis Inhibitors
DNA Synthesis Inhibitors
RNA Synthesis Inhibitors
Others

MARKET, BY DRUG CLASS

Fluoroquinolones
Cephalosporin
Penicillin
Macrolides
Carbapenems
Aminoglycosides
Other

MARKET, BY REGION

North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America

AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. Our company is led by a team of passionate, naturally curious, and strategic thinkers from different industry backgrounds.

These experts are dedicated to creating concrete market data analysis in various industries such as Healthcare, Bulk Chemicals, Semiconductors and Electronics, Foods and Beverages. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends.

Contact Us:
sales@analystviewmarketinsights.com
Mr Mayank +91-757-498-5725 (Asia-Pacific Centre)

11, Suajanya Phase, Opposite Eklavya Cross Road, Mumbai

This release was published on openPR.